Tag : T-Cell

Neurology

Safety Concern With Fingolimod to Ocrelizumab Switch in MS

Newsemia
A new study has suggested that some patients who make this switch may experience "double immunosuppression" – very low levels of both T and B...
Latest News

UofL receives $11.5 million to accelerate the development of new immunotherapies

Newsemia
Cancer remains one of the most difficult and deadly challenges in human health, affecting Kentuckians at a higher rate than residents of any other state...
Cardiology

A peripheral T-cell lymphoma (PTCL) arising as a post-transplant lymphoproliferative disorder: efficacy of pralatrexate in primary refractory disease and review of the literature.

Newsemia
Related Articles A peripheral T-cell lymphoma (PTCL) arising as a post-transplant lymphoproliferative disorder: efficacy of pralatrexate in primary refractory disease and review of the literature....
Latest News

Antibody and cellular immunity in severe vs. mild COVID-19

Newsemia
Now, a new study published in the journal Signal Transduction and Targeted Therapy in August 2020 shows that while humoral and T-cell immune responses are...
Latest News

Encouraging results from Phase I NovaVax SARS-CoV-2 nanoparticle vaccine trial

Newsemia
NVX-CoV2373, a recombinant nanoparticle vaccine developed by Novavax and manufactured at Emergent Biosolutions, was found to be well tolerated and immunogenic – inducing T-cell response...
Latest News

New bivalent vaccine delivers robust cell-mediated and humoral immunity against SARS-CoV-2

Newsemia
In a groundbreaking bioRxiv study, US researchers demonstrate the capability of next-generation bivalent human adenovirus serotype 5 (hAd5) vaccine for inducing both cellular and humoral...
Latest News

Arcturus and Duke-NUS announce approval of clinical trials for COVID-19 vaccine candidate

Newsemia
Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines,...
Latest News

Josep Carreras Institute's spin-off aims to develop new immuno-oncological therapeutic tools

Newsemia
The Josep Carreras Leukaemia Research Institute, a public centre pertaining to the Generalitat de Catalunya’s (Government of Catalonia) CERCA network, has created the OneChain Immunotherapeutics...
Latest News

Computational immunology paves the way for SARS-CoV-2 peptide cocktail vaccine candidate

Newsemia
By employing an immunoinformatics approach, a new study available on the preprint server bioRxiv* shows how the combination of peptides designed from severe acute respiratory...
Latest News

Temple researchers receive NIAID grant to study immunological synapse formation

Newsemia
Switching immune cells on is a critical step in combating infection. In the case of T cells, which are key players in immunity, this happens...
Latest News

Isolating Single T-cells of Interest using an Optofluidic Platform

Newsemia
Researchers are in desperate need of single-cell analysis techniques and those that allow the isolation of high-value T-cells for research and development. Source link...
Latest News

Universal 'One-Size-Fits-All' Cancer Treatment

Newsemia
Andrew Sewell speaks to News-Medical about his breakthrough research, in which he has discovered a new T-Cell that could treat most cancers. Source link...
Latest News

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

Newsemia
The growing trend of implementing immunotherapy into oncology has resulted in various new therapeutic cancer treatments utilizing antibodies. Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World